Regent Pacific Group Limited (FRA:RPG)

Germany · Delayed Price · Currency is EUR

0.1030

+0.0050 (5.10%)

Last updated: Jun 26, 2026, 5:00 PM CET

-3.74% (1Y)

Market Cap	31.65M +8.0%
Revenue (ttm)	309.17K -49.5%
Net Income	-4.01M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.1000
Previous Close	0.0980
Day's Range	0.1000 - 0.1030
52-Week Range	0.0550 - 0.1210
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Regent Pacific Group

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in the United States, Europe, and Asia Pacific. The company operates through two segments, Biopharma and Corporate Investment. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psycholo... [Read more]

Industry Investors, not elsewhere classified

Founded 1991

Employees 16

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol RPG

Financial Performance

In 2025, Regent Pacific Group's revenue was $363,000, a decrease of -49.51% compared to the previous year's $719,000. Losses were -$4.71 million, 5.09% more than in 2024.

Financial numbers in USD Financial Statements